Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Spero Therapeutics (SPRO) Shares Issued (2018 - 2023)

Spero Therapeutics' Shares Issued history spans 6 years, with the latest figure at $1000.0 for Q4 2023.

  • For Q4 2023, Shares Issued changed 0.0% year-over-year to $1000.0; the TTM value through Dec 2024 reached $221000.0, changed 0.0%, while the annual FY2023 figure was $221000.0, 47.38% down from the prior year.
  • Shares Issued reached $1000.0 in Q4 2023 per SPRO's latest filing, down from $220000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $40.0 million in Q2 2021 to a low of -$38.9 million in Q3 2021.
  • Average Shares Issued over 5 years is $2.3 million, with a median of $143000.0 recorded in 2019.
  • The largest YoY upside for Shares Issued was 3609.8% in 2020 against a maximum downside of 7216.33% in 2020.
  • A 5-year view of Shares Issued shows it stood at $98000.0 in 2019, then plummeted by 7216.33% to -$7.0 million in 2020, then soared by 103.33% to $232000.0 in 2021, then crashed by 99.57% to $1000.0 in 2022, then changed by 0.0% to $1000.0 in 2023.
  • Per Business Quant, the three most recent readings for SPRO's Shares Issued are $1000.0 (Q4 2023), $220000.0 (Q3 2023), and $1000.0 (Q4 2022).